Health

The new pill is also aimed at people who are doing well on a single-tablet regimen, including Biktarvy, and want to switch to a new treatment.

Taylor Farms and other suppliers have become larger and more integral to the U.S. food system, complicating foodborne illnesses such as cyclosporiasis.

Rare disease drug development is getting a boost from new funding models and a growing group of smaller biotech buyers.

HHS plans to name two deputy commissioners for technology and drugs, said two sources familiar with the matter.

The bigger issue at hand may be that many Americans fall into a large, uncertain middle ground – neither firmly pro-vaccine nor staunchly opposed.

The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.

BioMarin will acquire Alesta Therapeutics for $275 million upfront, bolstering BioMarin's unit focused on rare skeletal conditions.